Analyst Ratings for IO Biotech (IOBT)
IOBT Rating Summary
IOBT Price Target Summary
- Highest: $0.50 (Piper Sandler)
- Lowest: $0.36 (Morgan Stanley)
- Average: $0.43
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$0.43 (+43.3%)
* Over Last 12-Mos
Rating Score: 2 / 10
Percentile Rank: 15%
Avg. $ Target:
$0.43 (+43.3%)
* Over Last 12-Mos
Rating Score: 2 / 10
Percentile Rank: 15%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/26/2026 | Piper Sandler | Allison M. Bratzel | Downgrade | Neutral (Overweight) |
0.50 (3.00) |
0.48 (0.30) |
-37.5% | Details |
| 1/8/2026 | Morgan Stanley | Michael E Ulz | Downgrade | Underweight (Equalweight) |
0.36 (0.39) |
0.64 (0.30) |
-53.13% | Details |
 |
||||||||
|
||||||||
|
||||||||
